SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0001193125-20-047397
Filing Date
2020-02-25
Accepted
2020-02-25 09:00:32
Documents
2
Group Members
PROSIGHT FUND, LPPROSIGHT PARTNERS, LLCPROSIGHT PLUS FUND, LPW. LAWRENCE HAWKINS

Document Format Files

Seq Description Document Type Size
1 SC 13G d894278dsc13g.htm SC 13G 117000
2 EX-99.1 d894278dex991.htm EX-99.1 14226
  Complete submission text file 0001193125-20-047397.txt   133068
Mailing Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421
Business Address 131 HARTWELL AVENUE SUITE 320 LEXINGTON MA 02421 781-761-4904
Aldeyra Therapeutics, Inc. (Subject) CIK: 0001341235 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88182 | Film No.: 20647748
SIC: 2834 Pharmaceutical Preparations

Mailing Address 2301 CEDAR SPRINGS ROAD, SUITE 355 DALLAS TX 75201
Business Address 2301 CEDAR SPRINGS ROAD, SUITE 355 DALLAS TX 75201 214-468-0008
Prosight Management, LP (Filed by) CIK: 0001617201 (see all company filings)

IRS No.: 263706721 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G